author-photo

Sonja V. Sorensen

Boehringer Ingelheim

25

Papers

549

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Modeling Treatment Sequences in Pharmacoeconomic Models

2017 PharmacoEconomics
Show All
- Source
- Cite
- Save
Citations (10)
Comment on: “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal”

2017 PharmacoEconomics
Show All
- Source
- Cite
- Save
Citations (1)
Budgetary Impact on a U.S. Health Plan Adopting Abiraterone Acetate Plus Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer

2015 Journal of Managed Care Pharmacy
Show All
- Source
- Cite
- Save
Citations (20)
Efficacy and Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups

2014 American Journal of Cardiology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups

2014 American Journal of Cardiology
Show All
- Source
- Cite
- Save
Citations (17)
Comparison of the Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation in a UK Setting

2014 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (30)
A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation

2013 PharmacoEconomics
Show All
- Source
- Cite
- Save
Citations (14)
Modeling hard clinical end-point data in economic analyses

2013 Journal of Medical Economics
Show All
- Source
- Cite
- Save
Citations (5)
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness.

2012 Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (54)
Inclusion of Compliance and Persistence in Economic Models

2012 Applied Health Economics and Health Policy
Show All
- Source
- Cite
- Save
Citations (5)